Operating Expenses Summary of HANDOK Inc.

HANDOK Inc.'s latest annual operating expenses in 2023 was 153.76 Billion KRW , down -4.43% from previous year.
HANDOK Inc.'s latest quarterly operating expenses in 2024 Q2 was 37.18 Billion KRW , up 6.32% from previous quarter.
HANDOK Inc. reported a annual operating expenses of 145.21 Billion KRW in annual operating expenses 2022, up 4.07% from previous year.
HANDOK Inc. reported a annual operating expenses of 139.54 Billion KRW in annual operating expenses 2021, down -0.34% from previous year.
HANDOK Inc. reported a quarterly operating expenses of 34.97 Billion KRW for 2024 Q1, down -0.27% from previous quarter.
HANDOK Inc. reported a quarterly operating expenses of 37.18 Billion KRW for 2024 Q2, up 6.32% from previous quarter.

Annual Operating Expenses Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Operating Expenses of HANDOK Inc. (2023 - 2007)

Year	Operating Expenses	Operating Expenses Growth
2023	153.76 Billion KRW	-4.43%
2022	145.21 Billion KRW	4.07%
2021	139.54 Billion KRW	-0.34%
2020	140.01 Billion KRW	1.07%
2019	138.53 Billion KRW	2.09%
2018	135.68 Billion KRW	0.71%
2017	134.73 Billion KRW	8.77%
2016	123.86 Billion KRW	8.64%
2015	114.01 Billion KRW	9.54%
2014	104.08 Billion KRW	13.55%
2013	91.65 Billion KRW	0.85%
2012	90.88 Billion KRW	-10.96%
2011	102.07 Billion KRW	3.65%
2010	98.47 Billion KRW	1.66%
2009	96.86 Billion KRW	0.28%
2008	96.59 Billion KRW	-0.95%
2007	97.52 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	130.71 Billion KRW	5.9%
2024 Q1	34.97 Billion KRW	-0.27%
2024 Q2	37.18 Billion KRW	6.32%
2023 Q2	41.81 Billion KRW	15.57%
2023 Q1	36.17 Billion KRW	-0.67%
2023 FY	138.78 Billion KRW	-4.43%
2023 Q3	36.89 Billion KRW	-11.76%
2023 Q4	35.06 Billion KRW	-4.95%
2022 Q3	36.61 Billion KRW	0.94%
2022 Q2	36.27 Billion KRW	1.05%
2022 FY	145.21 Billion KRW	4.07%
2022 Q4	36.42 Billion KRW	-0.54%
2022 Q1	35.89 Billion KRW	-0.2%
2021 Q3	35.12 Billion KRW	0.27%
2021 Q1	33.42 Billion KRW	-16.07%
2021 Q2	35.02 Billion KRW	4.78%
2021 Q4	35.96 Billion KRW	2.42%
2021 FY	139.54 Billion KRW	-0.34%
2020 FY	140.01 Billion KRW	1.07%
2020 Q1	32.1 Billion KRW	-12.78%
2020 Q2	34.64 Billion KRW	7.91%
2020 Q4	39.82 Billion KRW	19.09%
2020 Q3	33.44 Billion KRW	-3.47%
2019 Q1	33.19 Billion KRW	-10.27%
2019 Q3	33.73 Billion KRW	-3.07%
2019 Q4	36.8 Billion KRW	9.13%
2019 FY	138.53 Billion KRW	2.09%
2019 Q2	34.79 Billion KRW	4.83%
2018 Q2	35.2 Billion KRW	6.63%
2018 Q4	36.99 Billion KRW	21.36%
2018 FY	135.68 Billion KRW	0.71%
2018 Q1	33.01 Billion KRW	-0.64%
2018 Q3	30.48 Billion KRW	-13.4%
2017 Q4	33.22 Billion KRW	-3.18%
2017 FY	134.73 Billion KRW	8.77%
2017 Q3	34.31 Billion KRW	-2.46%
2017 Q2	35.18 Billion KRW	9.93%
2017 Q1	32 Billion KRW	0.16%
2016 Q4	31.95 Billion KRW	3.98%
2016 Q1	29.46 Billion KRW	-4.57%
2016 FY	123.86 Billion KRW	8.64%
2016 Q2	31.71 Billion KRW	7.64%
2016 Q3	30.72 Billion KRW	-3.12%
2015 Q3	29.3 Billion KRW	7.81%
2015 Q1	26.64 Billion KRW	0.0%
2015 FY	114.01 Billion KRW	9.54%
2015 Q2	27.18 Billion KRW	2.04%
2015 Q4	30.87 Billion KRW	5.35%
2014 FY	104.08 Billion KRW	13.55%
2014 Q3	27.89 Billion KRW	1.12%
2014 Q2	27.59 Billion KRW	24.7%
2014 Q4	- KRW	-100.0%
2014 Q1	22.12 Billion KRW	-1.38%
2013 Q1	23.26 Billion KRW	-8.12%
2013 FY	91.65 Billion KRW	0.85%
2013 Q2	23.27 Billion KRW	0.03%
2013 Q3	22.67 Billion KRW	-2.57%
2013 Q4	22.43 Billion KRW	-1.06%
2012 Q4	25.32 Billion KRW	11.49%
2012 Q1	22.4 Billion KRW	0.0%
2012 Q2	20.41 Billion KRW	-8.88%
2012 Q3	22.71 Billion KRW	11.26%
2012 FY	90.88 Billion KRW	-10.96%
2011 FY	102.07 Billion KRW	3.65%
2011 Q4	- KRW	-100.0%
2011 Q3	28.04 Billion KRW	11.55%
2011 Q2	25.14 Billion KRW	9.32%
2011 Q1	22.99 Billion KRW	-11.48%
2010 Q1	25.87 Billion KRW	-2.02%
2010 FY	98.47 Billion KRW	1.66%
2010 Q2	21.43 Billion KRW	-17.16%
2010 Q3	25.2 Billion KRW	17.57%
2010 Q4	25.98 Billion KRW	3.08%
2009 Q1	23.68 Billion KRW	2.94%
2009 Q3	24.11 Billion KRW	6.24%
2009 Q2	22.69 Billion KRW	-4.15%
2009 Q4	26.41 Billion KRW	9.52%
2009 FY	96.86 Billion KRW	0.28%
2008 Q2	24.29 Billion KRW	-6.78%
2008 Q3	23.22 Billion KRW	-4.41%
2008 Q4	23 Billion KRW	-0.95%
2008 FY	96.59 Billion KRW	-0.95%
2008 Q1	26.06 Billion KRW	-0.66%
2007 Q4	26.24 Billion KRW	18.13%
2007 Q3	22.21 Billion KRW	-16.11%
2007 Q2	26.47 Billion KRW	17.22%
2007 Q1	22.58 Billion KRW	0.0%
2007 FY	97.52 Billion KRW	0.0%

Peer Operating Expenses Comparison of HANDOK Inc.

Name	Operating Expenses	Operating Expenses Difference
Yuyu Pharma, Inc.	47.25 Billion KRW	-225.409%
Dong-A Socio Holdings Co., Ltd.	297.99 Billion KRW	48.398%
Ildong Holdings Co., Ltd.	278.43 Billion KRW	44.775%
Kukje Pharma Co., Ltd.	69.21 Billion KRW	-122.165%
Yuhan Corporation	489.94 Billion KRW	68.615%
Dong-A ST Co., Ltd.	306.95 Billion KRW	49.906%
SAMSUNG PHARM. Co., LTD.	41.78 Billion KRW	-267.959%
Hanmi Pharm. Co., Ltd.	610.97 Billion KRW	74.832%
Hanall Biopharma Co.,Ltd	71.98 Billion KRW	-113.617%
Ilyang Pharmaceutical Co.,Ltd	174.14 Billion KRW	11.703%
Dong Sung Bio Pharm.Co.,Ltd.	40.05 Billion KRW	-283.911%
MYUNGMOON Pharm co.,Ltd	93.55 Billion KRW	-64.368%
Hana Pharm Co., Ltd.	114.72 Billion KRW	-34.032%
Yuyu Pharma, Inc.	47.25 Billion KRW	-225.409%
Ilsung Pharmaceuticals Co., Ltd.	42.47 Billion KRW	-262.049%
REYON Pharmaceutical Co., Ltd.	75.04 Billion KRW	-104.89%
Aprogen pharmaceuticals,Inc.	58.64 Billion KRW	-162.205%
JW Holdings Corporation	301.25 Billion KRW	48.958%
Ildong Pharmaceutical Co., Ltd.	260.95 Billion KRW	41.075%
Chong Kun Dang Pharmaceutical Corp.	408.65 Billion KRW	62.372%
JW Pharmaceutical Corporation	238.91 Billion KRW	35.638%
Shin Poong Pharm.Co.,Ltd.	127.66 Billion KRW	-20.443%
Hyundai Pharmaceutical Co., Ltd.	68.31 Billion KRW	-125.101%
Samil Pharmaceutical Co.,Ltd	65.75 Billion KRW	-133.863%
Jeil Pharmaceutical Co.,Ltd	174.92 Billion KRW	12.095%
Yuyu Pharma, Inc.	47.25 Billion KRW	-225.409%
Kwang Dong Pharmaceutical Co., Ltd.	249.12 Billion KRW	38.276%
Daewoong pharmaceutical Co.,Ltd	560.43 Billion KRW	72.562%
JW Pharmaceutical Corporation	238.91 Billion KRW	35.638%
Yuhan Corporation	489.94 Billion KRW	68.615%
Jeil Pharma Holdings Inc	193.66 Billion KRW	20.6%
Yungjin Pharm. Co., Ltd.	69.46 Billion KRW	-121.35%
Suheung Co., Ltd.	56.03 Billion KRW	-174.429%
JW Pharmaceutical Corporation	238.91 Billion KRW	35.638%
Samjin Pharmaceuticals Co., Ltd.	126.39 Billion KRW	-21.659%
Korea United Pharm Inc.	118.21 Billion KRW	-30.076%
CKD Bio Corp.	25.19 Billion KRW	-510.295%
Daewon Pharmaceutical Co., Ltd.	221.99 Billion KRW	30.735%
Dongwha Pharm.Co.,Ltd	165.11 Billion KRW	6.871%
Whan In Pharm Co.,Ltd.	66.41 Billion KRW	-131.518%
Shin Poong Pharm.Co.,Ltd.	127.66 Billion KRW	-20.443%
Chong Kun Dang Holdings Corp.	350.71 Billion KRW	56.156%
Boryung Corporation	285.16 Billion KRW	46.077%
Bukwang Pharmaceutical Co., Ltd.	87.54 Billion KRW	-75.651%
Ilyang Pharmaceutical Co.,Ltd	174.14 Billion KRW	11.703%
JW Lifescience Corporation	20.26 Billion KRW	-658.916%

Global Stocks Search

HANDOK Inc. (002390.KS)

Operating Expenses Summary of HANDOK Inc.

Annual Operating Expenses Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Operating Expenses of HANDOK Inc. (2023 - 2007)

Peer Operating Expenses Comparison of HANDOK Inc.